Estrella Immunopharma ESLA
NASDAQ ESLA
$0.70 +0.15 (+28.18%)
As of: Oct 22, 2026 · 3:21 PM EDT

Estrella Immunopharma (ESLA) EPS (Basic) (2021 - 2026)

Updated

Estrella Immunopharma (ESLA) reported EPS (Basic) of -$0.05 for Q2 2026.

Analysis

Estrella Immunopharma (ESLA) EPS (Basic) (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Estrella Immunopharma's EPS (Basic) came in at -$0.38; for FY2025, it came in at -$0.35.

  • By year, EPS (Basic) came in at -$0.12 in FY2024, -$3.43 in FY2023, -$0.56 in FY2022 and -$0.05 in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly EPS (Basic) since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,169.89 Bn 1,138.48 Bn 19.71 Bn 7.95
2 Johnson & Johnson 648.35 Bn 568.21 Bn 17.30 Bn 0.09
3 AbbVie 504.24 Bn 477.35 Bn 12.70 Bn 2.04
4 Merck 365.96 Bn 320.33 Bn 12.21 Bn -0.54
5 Novartis Ag 303.28 Bn 267.27 Bn 11.24 Bn 1.68
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 1.62
7 Amgen 242.76 Bn 198.16 Bn 7.24 Bn 4.40
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn -8.44
9 Pfizer 172.99 Bn 119.64 Bn 10.94 Bn -0.04
10 Estrella Immunopharma 30.46 Mn 25.37 Mn - -0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.05
Mar 31, 2026 -0.05
Dec 31, 2025 -0.06
Sep 30, 2025 -0.13
Jun 30, 2025 -0.15
Mar 31, 2025 -0.06
Sep 30, 2024 -0.09
Jun 30, 2024 -0.11
Mar 31, 2024 -0.01
Dec 31, 2023 -0.03
Sep 30, 2023 -1.78
Jun 30, 2023 -0.02
Mar 31, 2023 -1.93
Dec 31, 2022 -0.27
Sep 30, 2022 -2.03
Jun 30, 2022 -0.03
Mar 31, 2022 -0.01
Dec 31, 2021 -0.03
Sep 30, 2021 -0.01
Jun 30, 2021 0.00
API Access

Estrella Immunopharma EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=ESLA&period=max&api_key=YOUR_API_KEY